Despite recent advances in hepatic surgery, resection of the cirrhotic liver continues to be fraught with high morbidity and mortality rates. As a result, for many patients requiring resection of HCC the postoperative course is complicated and the probability of cure is diminished by coexisting cirrhosis. In this review, we discuss the characteristics of the cirrhotic liver which make it poorly tolerant of resection and the most common complications that follow such surgery. The main purpose of this paper is to review recent attempts to identify interventions that might be beneficial to cirrhotic patients undergoing resection. These interventions include assessment of liver reserve, advances in surgical technique, and improvement in liver function and regeneration.
INTRODUCTION
In the last 20 [4, 5] . Conversely, 10-20% of patients with cirrhosis from any etiology, will go on to develop HCC [3, 6] . Thus, the majority of patients who require resection also have cirrhosis or impaired liver function. An increased ability to safely perform resection in these patients should also lead to an increase in the surgical cure rate of hepatic malignancies, both primary and metastatic.
rently the subject of numerous investigations, but increased levels of circulating growth inhibitors such as ammonia, mercaptans, and GABA, rather than a paucity of growth stimulators is thought to be operative [9, 10] .
THE CIRRHOTIC LIVER
There are a number of factors that make it difficult for a cirrhotic patient to tolerate resection, including poor functional reserve, impaired regeneration, elevated portal venous pressures, and the characteristics of the patient population undergoing resection.
Reduced Function
The removal of functional liver tissue from an organ that already has marginal function can lead to many complications. If insufficient functioning hepatic parenchyma remains after resection, the patient will likely develop liver failure, which is the leading cause of death postoperatively. It is crucial to be able to resect a sufficient amount of liver to effect a cure, while leaving enough healthy liver to ensure survival. A minimum amount of liver function appears to be crucial to sustain life.
Impaired Regeneration
Unlike the normal liver, which, within [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] months can regenerate to its original size and function, even after 80% resection, the cirrhotic liver has impaired regenerative ability. Indeed, until recently, the cirrhotic liver was thought to be unable to regenerate [7] . However, we now know that while it is able to regenerate somewhat, the cirrhotic liver is greatly impaired both in rate and extent of regeneration [8] . The [13] .
Patient Population
The majority of patients requiring hepatic resection (particularly alcoholics with HCC), are in their 5th to 7th decades of life and will often have associated medical problems. Moreover, there is evidence to suggest that a number of hepatic changes are seen with aging, including decreased Reticuloendothelial System (RES) function [14] , decreased regeneration, and impaired mitochondrial enzyme activity [15] . Careful preoperative assessments and vigilant post-op monitoring are essential in managing these patients. [16] .
On the other hand, the risks and complications associated with resections in cirrhotic patients are more complex. The extent of resection and degree of baseline functional impairment appear to be the main independent risk factors. Other factors, such as bleeding tendency, ascites, anemia, and hypoalbuminemia appear to be dependent on these two variables [17, 18] . The serious complications that these patients are prone to develop are hepatic failure, sepsis, and bleeding, which can largely be attributed to insufficient hepatic function.
Cirrhotic patients are prone to these complications when undergoing surgery of any kind, not only hepatectomy. Doberneck examined cirrhotic patients undergoing a variety of operations including intraabdominal, genitourinary, and orthopedic procedures [19] . An overall complication rate of 47 [14] .
Bleeding
The factors predisposing the cirrhotic patient to bleeding are multiple and have been studied extensively. First of all, decreased hepatic synthetic function leads to low levels of clotting factors. The result is an abnormal PT/PTT. Due to the short half life of clotting factors (most under 1 day), PT is a sensitive indicator of acute changes in liver synthetic function [11] .
In addition, thrombocytopenia, associated with splenomegally, is often seen with chronic liver disease. Nonetheless, platelet counts rarely drop to low enough levels to contribute primarily to bleeding.
Portal Hypertension is also a factor in increased bleeding and collateral neovascularisation makes dissection difficult, particularly in the area of the porta hepatis. The classic paper by Schwartz Vasopressin, which was associated with a decrease in blood loss, and a shorter operating time [23] .
Over the last 20 years, the existence of a fibrinolytic state as well as the extent of its contribution to the problem of operative and postoperative blood loss has been debated.
When properly diagnosed, bleeding associated with a fibrinolytic state has been successfully controlled with the careful use of aminocaproic acid [12] . Another antifibrinolytic is Aprotinin (Trasylol(R)), a serine protease inhibitor which inhibits plasmin and kallikrein. It has been used successfully as an antifibrinolytic agent in cardiac surgery and liver transplantation [24] , and may similarly be beneficial to cirrhotic patients undergoing resection.
It is crucial to correct hemostasis preoperatively and to monitor hemostatic function closely postoperatively. Recent advancements in critical care have contributed significantly to the decrease in bleeding complications [25] .
POSSIBLE INTERVENTIONS
There are a number of approaches that can be undertaken to improve the outcome of cirrhotic patients undergoing hepatic resection: [22] . In a similar way, ICG15 was one of the major factors in Yamanaga's regression equation [17] , which will be discussed later.
Recently, Scudamore looked at preoperative tests in a similar fashion on 22 cirrhotic patients undergoing resection [29] . Again, ICG clearance was the only significant factor in predicting postoperative liver failure. Using discriminant analysis, the critical ICG clearance was found to be 5 [32] . IOUS is helpful in assessing the feasibility of resection as well as obtaining an accurate assessment of the extent of disease [32] . Relationships of the tumor to vascular structures as delineated by IOUS influenced the choice of operative procedure in 22 of 45 patients (49%) in one study [33] and 20 of 30 patients (67%) in another [34] . In the case of surgery for metastatic disease, IOUS was more sensitive than CT or preoperative ultrasound in detecting occult metastases under I cm in size [33] .
Other interventions have also been proposed, particularly methods to decrease the bleeding complications associated with cirrhosis. Techniques of occluding hepatic inflow (Pringle maneuver) and outflow are being investigated as means of reducing blood loss in healthy livers [16] . However, the ability of cirrhotic liver to tolerate blood flow occlusion has not yet been fully elucidated and may limit its use in this situation [35] . In a pilot study involving 15 patients with cirrhosis who had hepatic inflow occlusion (Pringle maneuver) for 9-32 minutes during hepatic resection, a significant decrease in blood loss was achieved compared to a similar group of 15 patients operated on without the use of blood flow occlusion. In addition, no hemodynamic complications resulted and no changes were seen in liver function studies, followed for up to 3 weeks post op in the blood flow occluded group [36] [38, 39] .
The use of the Lin liver clamp [40] is controversial, particularly in cirrhosis, because of the inhomogeneous texture and fibrous scarring present [16] . In addition, the neovascularisation associated with portal hypertension makes its application difficult and hazardous at times. A transdiaphragmatic approach to the right lobe has been advocated by one group to avoid the hypervascular porta hepatis area [41] [42] . The precise relationship between fibrosis and liver function or regenerative potential requires further investigation [43] . It is well known that the advanced cirrhotic liver possesses poor regenerative ability. As a result, a number of studies have attempted to reduce or prevent fibrosis and improve regeneration [44] .
Colchicine has been studied for many years and its effects have been well documented. This agent acts on many phases of collagen metabolism including decreased production and secretion, while increasing collagenase production [45] . In addition, colchicine affects lymphocyte and monocyte activity and these cells may contribute to the stimulation of myofibroblasts in the liver. The actions of colchicine appear to be on the incorporation of proline and independent of impairment of prolyl hydroxylase activity [44] . In vivo studies in the rat have suggested decreased fibrinogenesis and improved liver function [46] . A randomized controlled trial of Colchicine followed 100 patients for 3 to 14 years [47] . Histological improvement was suggested in the group receiving colchicine. Survival was also improved. Five year survival rates were 75% in the colchicine group versus 34% in the placebo group, while ten-year survival rates were 56% and 20% respectively. Long-term colchicine improved patient survival in cirrhosis, by preventing and reversing fibrosis. However, the colchicine and placebo treated groups were not well matched, and drop out rates were high. Moreover, it is not clear whether the beneficial effects can occur rapidly enough to be practical for preoperative preparation.
Pentoxifylline is a methylxanthine which has been used for years to improve blood flow in the lower limbs of patients with intermittent claudication. In a number of studies involving animal models of cirrhosis, pentoxifylline has been shown to decrease hepatic fibrinogenesis and improve serum liver function tests [48, 49] .
The mechanism involved is that of inhibition of Platelet-Derived Growth Factor (PDGF) induced fibrinogenesis, possibly by interfering with postreceptor second messenger signals involving the adenosine receptor. Other studies have shown a protective effect of adenosine in a rat model of cirrhosis [50] .
Ciprofloxacin, in addition to its antibiotic actions, has intrinsic GABA receptor blocking properties [9] . GABA receptors and transport proteins have been demonstrated on the surface of hepatocytes [51] and it has been shown that GABA has an inhibitory effect on hepatic regeneration [52] . In addition, elevated GABA levels are a common finding in the setting of acute or chronic liver disease [53] . Studies have shown that ciprofloxacin through its GABA blocking properties, enhances regeneration and protects against ethanol-and galactosamineinduced inhibition of regeneration [54] . This effect was independent of the antibiotic effect on the intestinal flora [55] .
A recent study has demonstrated a reduction in the degree of fibrotic change in cirrhosis, after a 4 week course of Ciprofloxacin in the CC14 induced cirrhotic rat model. In addition, liver function as measured by serum ALT was improved [56] . The effects on regeneration, fibrosis, and hepatocyte viability may be beneficial to the cirrhotic liver undergoing partial hepatectomy. Such studies are currently underway.
Traditional Chinese Herbal Remedies have been used for centuries in the treatment of liver disease. While many formulations exist, few have been well studied in a controlled scientific fashion. One specific formulation which contains many ingredients, including boiled turtle shell, leech, pangolin scales, and ginseng was found in a prospective, controlled trial to have a beneficial effect on the extent of hepatic fibrosis in a rat model of cirrhosis [56] . Fibrosis [57] . The many effects of HGF in vitro have been well documented; these include increased DNA synthesis, cell motility, and angiogenesis [58] . A favorable in vivo effect on regenerative activity has been shown in the mouse [59] , rat [60] , and dog [61] . These effects were seen not only after partial hepatectomy, but also in resting, healthy liver, as well. In other words regeneration occurred with HGF as the sole stimulus, whereas most other studies of liver growth factors only show an improvement in regeneration after a stimulus such as hepatic injury or partial hepatectomy.
The effects of HGF in vivo in the setting of cirrhosis require further study [62] . Moreover, its action is not specific, to the liver; similar effects have also been demonstrated in the lung, skin, kidney, and stomach [62] . High serum levels of HGF are seen in patients with cirrhosis or fulminant hepatic failure [63] , and it is possible that the cirrhotic liver is relatively unresponsive to HGF.
Portal Venous Embolization
Because of the dual blood supply to the liver (portal vein and hepatic artery), ligation of one blood supply is possible with less risk of infarction than in tissues with blood supply from a single vessel. In a rat model that dates back to 1920, ligation of one main portal venous branch led to atrophy of the lobes supplied by the branch. Of note, the other, non-ligated lobes were stimulated to hypertrophy [64] . Since then, the importance of hepatotrophic factors found in portal blood has been well established [65] .
This intervention has particular relevance to the treatment of hepatic malignancies, which, as discussed, commonly coexist with cirrhosis. induced cirrhosis in the rat [70] . Regeneration in cirrhotic rats as measured by 3 [H]-Thymidine incorporation was markedly impaired after hepatectomy. Cirrhotic rats treated with TGFalpha, however, achieved regeneration comparable to that in non-cirrhotic rats. TGF-alpha had no effect on regeneration in non-cirrhotic liver.
This study suggests that there is a relative deficiency of TGF-alpha in cirrhotic liver; whether this is due to decreased production, receptor downregulation, or the presence of competitive inhibitors will require further investigation.
Putrescine is a polyamine not only involved in hepatic regeneration, but also the growth of many tissues. Putrescine and the other polyamines appear to be essential for liver regeneration to take place [71] . Furthermore, the addition of exogenous putrescine was shown to enhance regeneration in models of acute liver disease [72] . Thus, a study was undertaken to determine the effect of putrescine at doses of 1, 10, and 100mg/kg given before and after partial hepatectomy in a rat model of cirrhosis. Nonetheless, no effect on regeneration was seen as measured by DNA synthesis or ODC activity. Part of this lack of effect could be due to the lack of change in hepatocyte putrescine levels achieved [73] .
Unfortunately, excessive regenerative activity could actually contribute to impaired liver function and lead to liver failure in the post operative period. This was suggested by Ito [74] Re[erences
